Oscar Health, Inc.: director Sankaran Sid received 1,472 shares

What happened Sankaran Sid, a director of Oscar Health, Inc., received 1,472 deferred stock units (reported as derivative shares) on Oct 8, 2026, at a price of $33.10 per unit for a total reported value of $48,723.

Key details

• Transaction date and price: Oct 8, 2026; 1,472 units at $33.10 each; total $48,723. Transaction type code: A (award/grant).
• Shares owned after the transaction: not reported in the filing.
• Footnotes of note:
  • F1: each deferred stock unit represents a right to receive one share of the issuer's Class A common stock.
  • F2: the deferred stock units will be settled for cash or shares, in the issuer's discretion, within 45 days of the first to occur of (i) termination of service; (ii) a change in control; (iii) death; or (iv) disability. DSUs issued in lieu of a cash retainer are 100% vested on the grant date.
  • F3: the reporting person elected to receive deferred stock units in lieu of cash retainer payments; the price used was the Oct 8, 2026 closing price of the Class A common stock.
• Filing timeliness: the Form 4 was filed Oct 13, 2026; the filing does not indicate it was filed late.

Why it may matter This filing reports a grant of deferred stock units (a derivative award) issued in lieu of a cash retainer, not an open-market purchase or sale; the units may be settled in cash or shares under the plan terms. A filing does not show why the insider traded or why the company acted.